Grunenthal Meds
Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal GmbH and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe.
Receive more information
Grunenthal Meds CPD Courses and Workshops
Send an enquiry
Use the form below to submit an enquiry to about
Grunenthal Meds CPD Online Learning
Send an enquiry
Use the form below to submit an enquiry to about
Grunenthal Meds Provider Events
Send an enquiry
Use the form below to submit an enquiry to about
Building 6, Galabank Business Park, Galashiels
Selkirkshire
United Kingdom
TD11QH